Continuous mRNA manufacturing to boost therapy and vaccine output
New mRNA-based therapies and vaccines could be developed more quickly and cheaply thanks to new manufacturing technologies developed at the University of Sheffield
Vaccine development focuses on creating immunizations to protect against infectious diseases. The process involves identifying antigens, developing and testing vaccine efficacy, and ensuring safety through preclinical testing and multiple clinical trial phases. Scientists use various approaches, including weakened or inactivated viruses, protein subunits, or mRNA. Advanced platforms and rapid diagnostic tools aid in vaccine research and testing. Explore vaccine development solutions in our peer-reviewed product directory; compare products, read reviews, and get pricing directly from manufacturers.
New mRNA-based therapies and vaccines could be developed more quickly and cheaply thanks to new manufacturing technologies developed at the University of Sheffield